Discover 219 paid clinical trials in Montana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you’re looking to join as a healthy volunteer in a paid clinical trial or need condition-specific options, Montana has a wide range of research opportunities to suit. Active recruitment is underway at research centers in Billings, Missoula, and Great Falls, allowing participants to access advanced treatments and high-quality medical care.
Filter
1
Filter results
Results: 219
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Missoula MT, Boise ID, Meridian ID, Bountiful UT,
Sponsor: Cidara Therapeutics Inc.
Sex: All
Age: 12+
Code: NCT07159763
Phase3, Recruiting
Active & Responsive
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
for
Asthma
Location: Missoula MT, Colorado Springs CO, Bakersfield CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 17
Code: NCT05757102
Phase3, Recruiting
Active & Responsive
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Billings MT, Las Vegas NV, Walnut Creek CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05139017
Phase2, Phase3, Recruiting
Active & Responsive
The PRIME Study: A Randomized, Controlled, Prospective Study
for
Patient Preference, Patient Outcomes,
Location: Bozeman MT
Sponsor: Vance Thompson Vision - MT
Sex: All
Age: 22 - 70+
Code: NCT04549935
Recruiting
Active & Responsive
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
for
Breast Neoplasms, Breast Cancer
Location: Billings MT, Tigard OR, Santa Monica CA, Skokie IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06797635
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
for
Gastrointestinal Cancer
Location: Billings MT, Madison WI, Cleveland OH, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06864169
Phase2, Recruiting
Active & Responsive
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Billings MT, Portland OR, Omaha NE, Saint Louis Park MN,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
Active & Responsive
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
for
Postmenopausal Osteoporosis
Location: Missoula MT, Burien WA, Albuquerque NM, Tucson AZ,